ENBRAFY Trademark

Trademark Overview


On Monday, June 20, 2016, a trademark application was filed for ENBRAFY with the United States Patent and Trademark Office. The USPTO has given the ENBRAFY trademark a serial number of 87077422. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 20, 2020. This trademark is owned by Array Biopharma Inc.. The ENBRAFY trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharma...
enbrafy

General Information


Serial Number87077422
Word MarkENBRAFY
Filing DateMonday, June 20, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 20, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2016

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 24, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameArray Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Party NameArray Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoulder, CO 80301

Trademark Events


Event DateEvent Description
Tuesday, January 21, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 20, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, May 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 14, 2019EXTENSION 5 GRANTED
Tuesday, May 7, 2019EXTENSION 5 FILED
Friday, May 10, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 7, 2019TEAS EXTENSION RECEIVED
Saturday, December 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 20, 2018EXTENSION 4 GRANTED
Thursday, December 20, 2018EXTENSION 4 FILED
Thursday, December 20, 2018TEAS EXTENSION RECEIVED
Wednesday, June 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 18, 2018EXTENSION 3 GRANTED
Monday, June 18, 2018EXTENSION 3 FILED
Monday, June 18, 2018TEAS EXTENSION RECEIVED
Thursday, December 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 5, 2017EXTENSION 2 GRANTED
Tuesday, December 5, 2017EXTENSION 2 FILED
Tuesday, December 5, 2017TEAS EXTENSION RECEIVED
Tuesday, May 16, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 12, 2017EXTENSION 1 GRANTED
Friday, May 12, 2017EXTENSION 1 FILED
Friday, May 12, 2017TEAS EXTENSION RECEIVED
Tuesday, December 20, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 25, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2016PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 15, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 15, 2016ASSIGNED TO EXAMINER
Friday, June 24, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 23, 2016NEW APPLICATION ENTERED IN TRAM